Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...

The global glioblastoma treatment drugs market is on the cusp of transformative growth. With market revenues expected to surge from approximately USD 844.8 million in 2025 to a projected USD 1,470.5 ...

Explore how nanosensors are transforming cancer diagnostics by enabling earlier, more accurate, and less invasive detection ...

DNA nanotechnology is a branch of nanotechnology concerned with the design, study and application of synthetic structures based on DNA. DNA nanotechnology takes advantage of the physical and ...

Nanoscale Advances is an international gold open access journal, publishing high-quality research across the breadth of nanoscience and nanotechnology. We are the first Royal Society of Chemistry ...

Recent research from the Nano Life Science Institute (WPI-NanoLSI) at Kanazawa University has unveiled a promising new approach to treating glioblastoma, a highly aggressive form of brain cancer.

At the core of Smoltek’s breakthrough is its signature carbon nanotechnology—a platform rooted in years of work studying how to grow carbon nanotubes in highly controlled and useful ways. These tiny ...

Get Instant Summarized Text (Gist) A targeted approach to glioblastoma treatment involves suppressing lysosomal function, which is linked to tumor progression and drug resistance. Lysosomal ...

The funding will help the Bengaluru-based company develop membranes that can lower the cost and improve the performance of clean energy systems, including batteries for energy storage and devices used ...

The protocol empowered patients with glioblastoma to make their own care decisions before cognitive decline. Researchers said the protocol could improve end of life quality. SAN DIEGO — An early ...

The Department of Science and Technology (DOST) Industrial Technology Development Institute developed a nanotechnology that can detect bacteria, viruses, and even cancer cells. Featured by Martin ...